# Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

> **NCT01164046** · PHASE3 · TERMINATED · sponsor: **University Medical Center Groningen** · enrollment: 56 (actual)

## Conditions studied

- Venous Thromboembolism
- Neoplasms

## Interventions

- **DRUG:** low molecular weight heparin
- **DRUG:** vitamin K antagonists

## Key facts

- **NCT ID:** NCT01164046
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Due to slow inclusion of patients
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164046, "Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01164046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*